LRP4 and myasthenia gravis: Background and Aims: Autoantibodies to the lipoprotein receptor‐related protein‐4 (anti‐LRP4) have been reported in a minority of patients with Myasthenia Gravis (MG), with potential pathogenic role and uncertain clinical relevance.